PCVX compared with FDMT: revenue, margins and what each company keeps, and the suppliers and customers both name

PCVXVaxcyte, Inc.

Mkt capRevenueRevenue

FDMT4D Molecular Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

PCVXVaxcyte, Inc.

FDMT4D Molecular Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PCVX 4

TMOPatheon Manufacturing Services LLC, part of Thermo Fisher Scientific (collectively, "Thermo Fisher")supplier

—Lonzaunlistedsupplier

—Sutro Biopharmaunlistedsupplier

—University of California, San Diegounlistedsupplier

Shared 0

No shared counterparties.

Only FDMT 6

QUREuniQurecustomer

—Cystic Fibrosis Foundationunlistedsupplier

—U.C. Berkeleyunlistedsupplier

—

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

University of Pennsylvania

unlistedsupplier

2 more · FDMT chain ›

PCVXVaxcyte, Inc.

63.89▲+3.18%· post 63.88

Mkt cap$9.8BRevenue—

FDMT4D Molecular Therapeutics, Inc.

12.26▲+9.00%· post 12.26

ClosedNov 6 '26

Mkt cap$884.2MRevenue$4MQ2 FY26

Compare

ClosedNov 6 '26

PCVXVaxcyte, Inc.

FDMT4D Molecular Therapeutics, Inc.

63.89▲+3.18%post 63.88

Price

12.26▲+9.00%post 12.26

$9.8B

Mkt cap

$884.2M

—

Revenue

$4MQ2 FY26

PCVX63.89▲+3.18%vsFDMT12.26▲+9.00%ClosedNov 6 '26